These findings not only indicate that sesamin could be a dietary-derived compound with potential anti-proliferative activity against cervical cancer cells, but also reveal that p53/Bax might be a potential target for the development of new cervical cancer treatment. This evidence concerns the gene BAX and cervical carcinoma.